This review aims to systematically review the pathophysiological roles of ERO1α in major human diseases including cardiovascular disorders, diabetes, cancer, and other diseases and discusses the associated challenges and future perspectives, with the goal of informing the development of novel ERO1α -targeted therapies. This evidence concerns the gene ERO1A and diabetes mellitus.